Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dayingpian is a traditional Chinese medicine formula that has been used in the treatment of bipolar disorder and other affective disorders. It is characterized by its effect of promoting blood circulation and reducing blood stasis. Dayingpian is a traditional Chinese medicine formula that has been prescribed as an add-on treatment for mental disorders, particularly bipolar disorder. It works by promoting blood circulation and reducing blood stasis, which are considered important mechanisms in traditional Chinese medicine for treating certain mental health conditions. The formula has been empirically combined with conventional medicines for affective disorders, suggesting it is used as a complementary therapy alongside standard psychiatric medications. While it has been used in clinical practice, there has been limited high-quality evidence regarding its clinical effectiveness, which has prompted recent clinical research to investigate its efficacy and safety.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dayingpian.